Business and People March 2014
Industry news focusing on the people and organizations who work in the clinical trials profession.
People
TrialNetworks (Needham, MA) announced the addition of Jose G. Guerra, MD, as Advisory Board Chairman. Guerra has been in the global biopharmaceutical industry for 30+ years, including 24 years at Merck.
ICON plc, (Dublin, Ireland) announced the appointment of Dariush Elahi, PhD, as Director of Metabolic Research. Based in ICON’s Clinical Pharmacology Unit in San Antonio, US, Elahi will lead ICON’s early phase glucose clamping programs globally.
INC Research (Camberley, UK) announced the appointment of two senior executives to its team. Asli Turkes, PhD, has joined as Vice President, Clinical Development, Oncology. Susan Timoney, PhD, has joined as Executive Director, Clinical Development, Oncology. INC also announced the addition of Beatrice Setnik, PhD, as Vice President, Clinical Pharmacology; and Jane Winter as Senior Vice President of its Global Consulting Unit.
Covance (Princeton, NJ) announced that Barry J. Goldstein, MD, PhD, has joined its Clinical Development Services business as Vice President and Global Therapeutic Area Head of the expanded Cardiovascular, Metabolic, and Scientific Affaris leadership team.
Vetter Development Services USA, Inc. (Chicago, IL) announced that President Claudia Roth, PhD, was elected to the board of the Illinois Biotechnology Industry Organization.
Synergy Research Group, (St. Petersburg, Russia) a Russia-based CRO, announced that John Barker has joined the company as COO. Barker’s role will be focused on expanding Synergy’s business into clients in the USA. Barker has previously served as VP of Project Management at Quintiles.
Waife & Associates, Inc. (Needham, MA) announced the addition of Senior Associate, Siegbert Kloos, to its staff.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) (Brussels, Belgium) announced Liam English as its new Communications Director.
Exco InTouch (Sawbridgeworth, UK) announced the appointment of Laurence Burke as Vice President of Operations. His responsibilities include ensuring that processes are as streamlined and efficient as possible for customers, while also ensuring full continuity of robust delivery programs as Exco InTouch continues to grow the volume of its business.
Novella Clinical, (Stevenage, England) a Quintiles company, announced the addition of Chris Smyth, PhD, MBA, as their new Managing Director of European and Asian Operations.
CluePoints (Cambridge, MA) announced three new appointments to its global team. John Colby and Elizabeth Polvent join the company’s US Business Development Team. Jean Stéphenne, President of the Board of Directors of GlaxoSmithKline Biologicals, was welcomed as a member of its board.
Awards
ERT (Philadelphia, PA) announced that Philadelphia SmartCEO has recognized the company in its Future 50 Awards program. The program recognizes the region’s fastest-growing mid-sized and large Blue Chip companies that have experienced outsized growth based on a combined three-year average of revenue and employee growth.
Pharmaceutical Product Development, LLD (PPD) (Wilmington, NC) announced the company was ranked among the top US businesses for employee learning and development by Training magazine. The recognition marks the third consecutive ranking for PPD on the annual Training Top 125 list.
DAC Patient Recruitment Services (Dallas, TX) announced that it took home the gold in the 2014 AVA Digital Awards competition of writing, design, and execution of its DACTracks digital marketing campaign.
Forte Research Systems, Inc. (Madison, WI) announced that the Research Resonance Network received the Clinical Informatics News Best Practices Award in the category of Clinical Data Intelligence. The Research Resonance Network—which was developed through collaboration with research organizations and offers free tools for continuous improvement—was recognized for its standards-based approach to improving clinical research operations.
CTI Clinical Trial and Consulting Services (CTI) (Cincinnati, OH) was named Blue Ash Corporation of the Year by the Cincinnati USA Regional Chamber. The award recognizes outstanding companies in one of Cincinnati USA’s most vibrant business communities.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 1st 2025In this pilot episode of the Applied Clinical Trials Brief, we examine the renewed push for placebo-controlled vaccine trials in the US, why experts warn it violates core ethical standards, and how these proposals could jeopardize both participant safety and future innovation.
Cardiff Reports 49% Response Rate With Onvansertib in RAS-Mutated Colorectal Cancer
August 1st 2025In the ongoing Phase II CRDF-004 trial, onvansertib plus standard-of-care showed a 49% confirmed ORR and early PFS benefit in first-line RAS-mutated metastatic colorectal cancer, with a favorable safety profile and dose-dependent efficacy across endpoints.
Unifying Industry to Better Understand GCP Guidance
August 1st 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
